Nantahala Capital Management, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Nantahala Capital Management, LLC reported 118 stock positions worth $1.4 billion. Its top holding was Soleno Therapeutics (SLNO) at 12.4% of the portfolio, followed by Establishment Labs (ESTA, 5.3%) and Hilton Grand Vacations (HGV, 4.7%). Compared with Q3 2024, it opened 16 new positions, sold out of 17, added to 43 and reduced 25. The biggest buy was Hilton Grand Vacations (HGV, shares +132%) and the biggest sale Establishment Labs (ESTA, shares −30%).
- Most Recent 13F
- Q2 2026
- Location
- NEW CANAAN, CT
- CIK
- 0001472322
- Portfolio Value
- $1.4B (Q4 2024)
- SEC Filing
- 0001104659-25-014223 ↗ filed Feb 14, 2025
Holdings Value
Holdings 118 stocks · $1.4B
| SLNO Soleno Therapeutics Inc. | 12.35% | 3,928,966 | $176.6M | Add +20.1% |
| ESTA Establishment Labs Holdings | 5.33% | 1,654,470 | $76.2M | Reduce -29.9% |
| HGV Hilton Grand Vacations Inc. | 4.72% | 1,730,995 | $67.4M | Add +131.8% |
| PTON Peloton Interactive Inc. Class A | 4.40% | 7,224,903 | $62.9M | Reduce -30.2% |
| TBBK The Bancorp Inc. | 3.59% | 974,455 | $51.3M | Add +65.7% |
| QURE Uniqure NV | 3.03% | 2,453,364 | $43.3M | Reduce -11.8% |
| BVS Bioventus Inc. Class A | 2.96% | 4,026,809 | $42.3M | Reduce -7.5% |
| EOLS Evolus Inc. | 2.42% | 3,130,149 | $34.6M | Add +10.8% |
| IMAX Imax Corp. | 2.06% | 1,150,351 | $29.4M | Reduce -10.0% |
| AMRX Amneal Pharmaceuticals Inc. | 2.03% | 3,665,529 | $29.0M | Add +37.3% |
| CRMT America's Car-Mart Inc. | 1.95% | 544,686 | $27.9M | No change |
| SVRA Savara Inc. | 1.62% | 7,525,259 | $23.1M | Add +45.3% |
| TITN Titan Machinery Inc. | 1.61% | 1,625,276 | $23.0M | No change |
| FULC Fulcrum Therapeutics Inc. | 1.57% | 4,779,708 | $22.5M | Add +0.0% |
| IWM iShares Russell 2000 ETF | 1.51% | 97,637 | $21.6M | Add +4088.6% |
| GOGO Gogo Inc. | 1.46% | 2,574,642 | $20.8M | Add +441.5% |
| SVC Service Pptys TR | 1.44% | 8,091,900 | $20.6M | New |
| EB Eventbrite Inc. Class A | 1.39% | 5,930,947 | $19.9M | Add +76.5% |
| ABEO Abeona Therapeutics Inc. | 1.38% | 3,529,214 | $19.7M | Add +2.8% |
| ZVRA Zevra Therapeutics Inc. | 1.37% | 2,340,333 | $19.5M | Reduce -20.0% |
| VSTM Verastem Inc. | 1.36% | 3,752,583 | $19.4M | Add +0.5% |
| FOXF Fox Factory Holding Corp. | 1.35% | 635,994 | $19.3M | New |
| EHTH Ehealth Inc. | 1.32% | 2,009,500 | $18.9M | Add +5.1% |
| RDNW Ridenow Group Inc. filed as RUMBLEON INC | 1.24% | 3,274,138 | $17.8M | Add +6.8% |
| PAYO Payoneer Global Inc. | 1.08% | 1,538,600 | $15.4M | Reduce -27.3% |
| RDVT Red Violet Inc. | 1.07% | 422,466 | $15.3M | Reduce -6.6% |
| ETON Eton Pharmaceuticals Inc. | 1.04% | 1,118,483 | $14.9M | Add +12.0% |
| BKSY Blacksky Technology Inc. | 1.04% | 1,377,060 | $14.9M | Reduce -43.8% |
| URGN Urogen Pharma Ltd. | 1.02% | 1,371,638 | $14.6M | New |
| KROS Keros Therapeutics Inc. | 1.01% | 915,048 | $14.5M | Add +139.8% |
| RSVR Reservoir Media Inc. | 0.99% | 1,560,797 | $14.1M | No change |
| CASH Pathward Financial Inc. | 0.98% | 191,343 | $14.1M | Reduce -27.6% |
| RZLT Rezolute Inc. | 0.98% | 2,857,982 | $14.0M | Add +10.9% |
| CDXS Codexis Inc. | 0.95% | 2,841,660 | $13.6M | Reduce -4.3% |
| TELA Tela Bio Inc. | 0.78% | 3,679,726 | $11.1M | Add +92.1% |
| TRML Tourmaline Bio Inc. | 0.76% | 536,944 | $10.9M | Reduce -23.4% |
| ELUT Elutia Inc. | 0.75% | 2,864,947 | $10.7M | No change |
| BNTC Benitec Biopharma Inc. | 0.74% | 838,095 | $10.6M | No change |
| ABVX Abivax SA-ADR | 0.74% | 1,436,047 | $10.5M | Add +45.7% |
| AURA Aura Biosciences Inc. | 0.73% | 1,270,035 | $10.4M | No change |
| UPB Upstream Bio Inc. | 0.69% | 600,000 | $9.9M | New |
| IRON Disc Medicine Inc. | 0.67% | 150,000 | $9.5M | No change |
| RMR RMR Group Inc./the - A | 0.65% | 450,792 | $9.3M | Add +32.8% |
| AVR Anteris Technologies Global | 0.65% | 1,666,666 | $9.3M | New |
| TNGX Tango Therapeutics Inc. | 0.61% | 2,804,410 | $8.7M | New |
| CNTA Centessa Pharmaceuticals Ltd. | 0.60% | 512,647 | $8.6M | No change |
| UNICYCIVE THERAPEUTICS INC | 0.58% | 10,391,994 | $8.3M | Add +268.5% |
| MLYS Mineralys Therapeutics Inc. | 0.54% | 632,506 | $7.8M | No change |
| ILPT Industrial Logistics Propert | 0.54% | 2,107,893 | $7.7M | Add +86.3% |
| VMD Viemed Healthcare Inc. | 0.52% | 935,122 | $7.5M | Reduce -17.6% |
| SNDX Syndax Pharmaceuticals Inc. | 0.52% | 560,532 | $7.4M | Add +23.7% |
| NKTR Nektar Therapeutics | 0.51% | 7,810,000 | $7.3M | Add +90.0% |
| SLN Silence Therapeutics PLC-ADR | 0.51% | 1,049,676 | $7.2M | Add +424.8% |
| IKT Inhibikase Therapeutics Inc. | 0.50% | 2,190,000 | $7.1M | New |
| ASSERTIO HOLDINGS INC | 0.50% | 8,148,336 | $7.1M | Reduce -8.9% |
| COGT Cogent Biosciences Inc. | 0.47% | 852,855 | $6.7M | Add +7.8% |
| OPTINOSE INC | 0.46% | 986,031 | $6.6M | Add +3.0% |
| NPCE Neuropace Inc. | 0.44% | 562,073 | $6.3M | Reduce -7.5% |
| STKS One Group Hospitality Inc. filed as THE ONE GROUP HOSPITALITY IN | 0.42% | 2,087,394 | $6.1M | Add +23.9% |
| ATXS Astria Therapeutics Inc. | 0.42% | 675,000 | $6.0M | No change |
| GPCR Structure Therapeutics Inc. | 0.42% | 221,000 | $6.0M | Add +29.2% |
| VTGN Vistagen Therapeutics Inc. | 0.41% | 1,981,980 | $5.8M | Add +30.6% |
| FOSL Fossil Group Inc. | 0.39% | 3,326,677 | $5.6M | Add +74.6% |
| ALTG Alta Equipment Group Inc. | 0.39% | 845,115 | $5.5M | No change |
| AMLX Amylyx Pharmaceuticals Inc. | 0.38% | 1,452,153 | $5.5M | Add +3.4% |
| THRD Third Harmonic Bio Inc. | 0.36% | 501,000 | $5.2M | New |
| ANEB Anebulo Pharmaceuticals Inc. | 0.36% | 3,036,325 | $5.1M | Add +494.1% |
| XTNT Xtant Medical Holdings Inc. | 0.35% | 11,394,000 | $5.0M | No change |
| APYX Apyx Medical Corp. | 0.35% | 3,169,800 | $5.0M | New |
| LXRX Lexicon Pharmaceuticals Inc. | 0.34% | 6,604,150 | $4.9M | Add +186.6% |
| THTX Theratechnologies Inc. | 0.34% | 2,682,228 | $4.9M | No change |
| NNBR NN Inc. | 0.33% | 1,458,416 | $4.8M | No change |
| ELDN Eledon Pharmaceuticals Inc. | 0.33% | 1,147,946 | $4.7M | Add +91.3% |
| EYPT Eyepoint Inc. | 0.31% | 600,000 | $4.5M | New |
| NSPR Inspiremd Inc. | 0.31% | 1,674,565 | $4.4M | Reduce -24.2% |
| DHX Dhi Group Inc. | 0.29% | 2,376,606 | $4.2M | No change |
| IMTX Immatics NV | 0.29% | 578,856 | $4.1M | Reduce -7.5% |
| GAIA Gaia Inc. | 0.29% | 915,029 | $4.1M | No change |
| ZYXIQ Zynex Inc. | 0.27% | 490,000 | $3.9M | No change |
| RDI Reading International Inc. Class A | 0.26% | 2,864,046 | $3.8M | Reduce -11.5% |
| CMPS Compass Pathways PLC | 0.26% | 1,000,000 | $3.8M | Add +400.0% |
| OCUL Ocular Therapeutix Inc. | 0.26% | 437,728 | $3.7M | Reduce -37.5% |
| SCPH Scpharmaceuticals Inc. | 0.25% | 1,000,000 | $3.5M | Add +33.3% |
| MIST Milestone Pharmaceuticals Inc. | 0.24% | 1,445,264 | $3.4M | Reduce -17.4% |
| SRL Scully Royalty Ltd. | 0.24% | 368,596 | $3.4M | Add +54.1% |
| CZR Caesars Entertainment Inc. | 0.23% | 100,000 | $3.3M | New |
| PVLA Palvella Therapeutics Inc. | 0.21% | 250,062 | $3.0M | New |
| SRZN Surrozen Inc. | 0.20% | 196,023 | $2.8M | Add +4.7% |
| KOD Kodiak Sciences Inc. | 0.19% | 266,613 | $2.7M | Add +287.2% |
| NDLS Noodles & Co. | 0.18% | 4,508,329 | $2.6M | No change |
| ACHV Achieve Life Sciences Inc. | 0.16% | 654,000 | $2.3M | No change |
| CNTX Context Therapeutics Inc. | 0.14% | 1,935,484 | $2.0M | No change |
| RAPT THERAPEUTICS INC | 0.14% | 1,243,513 | $2.0M | New |
| DRIO Dariohealth Corp. | 0.13% | 2,444,677 | $1.9M | Reduce -2.3% |
| AYTU Aytu Biopharma Inc. | 0.13% | 1,086,812 | $1.8M | No change |
| NVNO Envveno Medical Corporation | 0.13% | 596,917 | $1.8M | No change |
| BCOV Brightcove | 0.11% | 358,052 | $1.6M | Reduce -78.5% |
| PERF Perfect Corp. | 0.10% | 500,000 | $1.4M | Add +19.3% |
| ALTISOURCE PORTFOLIO SOLNS S | 0.10% | 2,128,284 | $1.4M | Add +95.1% |
| MAX Mediaalpha Inc. Class A | 0.10% | 123,564 | $1.4M | No change |
| TYRA Tyra Biosciences Inc. | 0.10% | 100,000 | $1.4M | New |
| SGRP Spar Group Inc. | 0.09% | 662,028 | $1.3M | No change |
| AEROVATE THERAPEUTICS INC | 0.09% | 482,928 | $1.3M | New |
| BIOMX INC | 0.09% | 1,730,600 | $1.2M | No change |
| SSKN Strata Skin Sciences Inc. | 0.08% | 403,917 | $1.2M | No change |
| TLPH Talphera Inc. | 0.07% | 1,992,519 | $1.0M | No change |
| KPRX Kiora Pharmaceuticals Inc. | 0.05% | 211,110 | $697K | No change |
| APRE Aprea Therapeutics Inc. | 0.05% | 205,760 | $677K | No change |
| EVOK Evoke Pharma Inc. | 0.05% | 148,194 | $655K | Add +163.5% |
| LAZYDAYS HLDGS INC | 0.04% | 551,135 | $526K | No change |
| OKUR Onkure Therapeutics Inc. Class A | 0.03% | 54,777 | $471K | New |
| EWTX Edgewise Therapeutics Inc. | 0.03% | 13,371 | $357K | No change |
| PLCE The Children's Place Inc. | 0.02% | 29,314 | $307K | No change |
| LADR Ladder Capital Corp.-REIT | 0.02% | 25,631 | $287K | No change |
| XGN Exagen Inc. | 0.02% | 62,116 | $255K | No change |
| FBIO Fortress Biotech Inc. | 0.02% | 125,520 | $254K | Reduce -18.0% |
| LUCD Lucid Diagnostics Inc. | 0.01% | 94,541 | $77K | Reduce -25.2% |
| TACT Transact Technologies Inc. | 0.00% | 15,046 | $62K | Reduce -25.2% |
Options reported separately and not counted above: IWM puts ($530.3M), LLY puts ($123.5M), XBI puts ($112.6M), PTON calls ($44.3M), SYK puts ($36.0M), RDNW calls ($9.2M), KRYS puts ($7.8M), CZR calls ($6.7M), IMAX calls ($6.4M), HLF calls ($5.4M), GPCR calls ($4.1M), KROS calls ($4.0M), and 3 more.
Other holdings (4): bonds, preferreds, convertibles and warrants · $120K (not counted above)
Total filed on the 13F, all lines: $1.4B.
Portfolio Sells Q3 2024 → Q4 2024
| ESTA Establishment Labs Holdings | Reduce -29.9% | 5.33% | −3.26 |
| BVS Bioventus Inc. Class A | Reduce -7.5% | 2.96% | −1.42 |
| PWSC Powerschool Holdings Inc. Class A | Sold out | 0.00% | −1.12 |
| TRML Tourmaline Bio Inc. | Reduce -23.4% | 0.76% | −0.76 |
| EGRX Eagle Pharmaceuticals Inc. | Sold out | 0.00% | −0.74 |
| VNDA Vanda Pharmaceuticals Inc. | Sold out | 0.00% | −0.63 |
| CLRB Cellectar Biosciences Inc. | Sold out | 0.00% | −0.49 |
| CASH Pathward Financial Inc. | Reduce -27.6% | 0.98% | −0.48 |
| LXFR Luxfer Holdings PLC | Sold out | 0.00% | −0.45 |
| ASSERTIO HOLDINGS INC | Reduce -8.9% | 0.50% | −0.39 |
| ZVRA Zevra Therapeutics Inc. | Reduce -20.0% | 1.37% | −0.34 |
| IMTX Immatics NV | Reduce -7.5% | 0.29% | −0.31 |
| PAYO Payoneer Global Inc. | Reduce -27.3% | 1.08% | −0.26 |
| OCUL Ocular Therapeutix Inc. | Reduce -37.5% | 0.26% | −0.25 |
| BCOV Brightcove | Reduce -78.5% | 0.11% | −0.19 |
| NSPR Inspiremd Inc. | Reduce -24.2% | 0.31% | −0.19 |
| XBI SS SPDR S&P Biotech ETF | Sold out | 0.00% | −0.18 |
| RDI Reading International Inc. Class A | Reduce -11.5% | 0.26% | −0.18 |
| VMD Viemed Healthcare Inc. | Reduce -17.6% | 0.52% | −0.18 |
| NGNE Neurogene Inc. | Sold out | 0.00% | −0.15 |
| IMAX Imax Corp. | Reduce -10.0% | 2.06% | −0.15 |
| RNTX Rein Therapeutics Inc. | Sold out | 0.00% | −0.14 |
| TIL Instil Bio Inc. | Sold out | 0.00% | −0.11 |
| DRIO Dariohealth Corp. | Reduce -2.3% | 0.13% | −0.10 |
| RENEO PHARMACEUTICALS INC | Sold out | 0.00% | −0.08 |
| NEUROONE MED TECHNOLOGIES CO | Sold out | 0.00% | −0.07 |
| RILY BRC Group Holdings Inc. | Sold out | 0.00% | −0.06 |
| GOSS Gossamer Bio Inc. | Sold out | 0.00% | −0.06 |
| BMTX BM Technologies Inc. | Sold out | 0.00% | −0.02 |
| RDVT Red Violet Inc. | Reduce -6.6% | 1.07% | −0.01 |
| TACT Transact Technologies Inc. | Reduce -25.2% | 0.00% | −0.00 |
| LUCD Lucid Diagnostics Inc. | Reduce -25.2% | 0.01% | −0.00 |
| APTOSE BIOSCIENCES INC | Sold out | 0.00% | −0.00 |
| RENALYTIX AI PLC-ADR | Sold out | 0.00% | −0.00 |
| KINTARA THERAPEUTICS INC | Sold out | 0.00% | −0.00 |
| FBIO Fortress Biotech Inc. | Reduce -18.0% | 0.02% | −0.00 |
| MIST Milestone Pharmaceuticals Inc. | Reduce -17.4% | 0.24% | +0.01 |
| BKSY Blacksky Technology Inc. | Reduce -43.8% | 1.04% | +0.06 |
| NPCE Neuropace Inc. | Reduce -7.5% | 0.44% | +0.08 |
| CDXS Codexis Inc. | Reduce -4.3% | 0.95% | +0.18 |
| PTON Peloton Interactive Inc. Class A | Reduce -30.2% | 4.40% | +0.32 |
| QURE Uniqure NV | Reduce -11.8% | 3.03% | +1.88 |
Portfolio Buys Q3 2024 → Q4 2024
| HGV Hilton Grand Vacations Inc. | Add +131.8% | 4.72% | +2.43 |
| IWM iShares Russell 2000 ETF | Add +4088.6% | 1.51% | +1.47 |
| SVC Service Pptys TR | New | 1.44% | +1.44 |
| FOXF Fox Factory Holding Corp. | New | 1.35% | +1.35 |
| GOGO Gogo Inc. | Add +441.5% | 1.46% | +1.17 |
| URGN Urogen Pharma Ltd. | New | 1.02% | +1.02 |
| TBBK The Bancorp Inc. | Add +65.7% | 3.59% | +0.94 |
| UPB Upstream Bio Inc. | New | 0.69% | +0.69 |
| EHTH Ehealth Inc. | Add +5.1% | 1.32% | +0.66 |
| AVR Anteris Technologies Global | New | 0.65% | +0.65 |
| EB Eventbrite Inc. Class A | Add +76.5% | 1.39% | +0.62 |
| TNGX Tango Therapeutics Inc. | New | 0.61% | +0.61 |
| ETON Eton Pharmaceuticals Inc. | Add +12.0% | 1.04% | +0.54 |
| IKT Inhibikase Therapeutics Inc. | New | 0.50% | +0.50 |
| UNICYCIVE THERAPEUTICS INC | Add +268.5% | 0.58% | +0.48 |
| VSTM Verastem Inc. | Add +0.5% | 1.36% | +0.42 |
| TELA Tela Bio Inc. | Add +92.1% | 0.78% | +0.37 |
| THRD Third Harmonic Bio Inc. | New | 0.36% | +0.36 |
| APYX Apyx Medical Corp. | New | 0.35% | +0.35 |
| EYPT Eyepoint Inc. | New | 0.31% | +0.31 |
| ANEB Anebulo Pharmaceuticals Inc. | Add +494.1% | 0.36% | +0.27 |
| CZR Caesars Entertainment Inc. | New | 0.23% | +0.23 |
| PVLA Palvella Therapeutics Inc. | New | 0.21% | +0.21 |
| ELDN Eledon Pharmaceuticals Inc. | Add +91.3% | 0.33% | +0.21 |
| FOSL Fossil Group Inc. | Add +74.6% | 0.39% | +0.20 |
| SLN Silence Therapeutics PLC-ADR | Add +424.8% | 0.51% | +0.20 |
| KOD Kodiak Sciences Inc. | Add +287.2% | 0.19% | +0.17 |
| AMRX Amneal Pharmaceuticals Inc. | Add +37.3% | 2.03% | +0.16 |
| CMPS Compass Pathways PLC | Add +400.0% | 0.26% | +0.16 |
| RAPT THERAPEUTICS INC | New | 0.14% | +0.14 |
| FULC Fulcrum Therapeutics Inc. | Add +0.0% | 1.57% | +0.14 |
| TYRA Tyra Biosciences Inc. | New | 0.10% | +0.10 |
| AEROVATE THERAPEUTICS INC | New | 0.09% | +0.09 |
| ILPT Industrial Logistics Propert | Add +86.3% | 0.54% | +0.08 |
| SRL Scully Royalty Ltd. | Add +54.1% | 0.24% | +0.08 |
| NKTR Nektar Therapeutics | Add +90.0% | 0.51% | +0.06 |
| LXRX Lexicon Pharmaceuticals Inc. | Add +186.6% | 0.34% | +0.04 |
| OKUR Onkure Therapeutics Inc. Class A | New | 0.03% | +0.03 |
| PERF Perfect Corp. | Add +19.3% | 0.10% | +0.03 |
| VTGN Vistagen Therapeutics Inc. | Add +30.6% | 0.41% | +0.02 |
| EVOK Evoke Pharma Inc. | Add +163.5% | 0.05% | +0.02 |
| SRZN Surrozen Inc. | Add +4.7% | 0.20% | +0.01 |
| RDNW Ridenow Group Inc. | Add +6.8% | 1.24% | +0.01 |
| AMLX Amylyx Pharmaceuticals Inc. | Add +3.4% | 0.38% | +0.00 |
| ALTISOURCE PORTFOLIO SOLNS S | Add +95.1% | 0.10% | −0.01 |
| SCPH Scpharmaceuticals Inc. | Add +33.3% | 0.25% | −0.04 |
| RZLT Rezolute Inc. | Add +10.9% | 0.98% | −0.07 |
| RMR RMR Group Inc./the - A | Add +32.8% | 0.65% | −0.07 |
| STKS One Group Hospitality Inc. | Add +23.9% | 0.42% | −0.10 |
| GPCR Structure Therapeutics Inc. | Add +29.2% | 0.42% | −0.21 |
Options Activity Q3 2024 → Q4 2024
| IWM iShares Russell 2000 ETF | put | Add +29.7% | 2,400,000 | $530.3M |
| LLY Eli Lilly & Co. | put | Add +77.8% | 160,000 | $123.5M |
| XBI SS SPDR S&P Biotech ETF | put | Add +56.3% | 1,250,000 | $112.6M |
| LOPE Grand Canyon Education Inc. | put | Sold out | 400,000 | $56.7Mbefore exit |
| PTON Peloton Interactive Inc. Class A | call | Reduce -38.6% | 5,089,700 | $44.3M |
| SYK Stryker Corp. | put | Reduce -16.7% | 100,000 | $36.0M |
| ENVA Enova International Inc. | call | Sold out | 109,000 | $9.1Mbefore exit |
| KRYS Krystal Biotech Inc. | put | Reduce -7.2% | 50,000 | $7.8M |
| IMAX Imax Corp. | call | Reduce -83.3% | 250,000 | $6.4M |
| GPCR Structure Therapeutics Inc. | call | New | 150,000 | $4.1M |
| KROS Keros Therapeutics Inc. | call | New | 250,000 | $4.0M |
| EGRX Eagle Pharmaceuticals Inc. | call | Sold out | 1,000,000 | $3.7Mbefore exit |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q3 2024 → Q4 2024
| LMND.WS Lemonade Inc.-28 | *W EXP 02/09/202 | Sold out | 507,460 | $16Kbefore exit |
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026Amended | 128 | $1.6B | TBBK, BVS, HGV, SVRA, ETON |
| Q1 2026 | 125 | $1.6B | TBBK, HGV, SLNO, BVS, PTON |
| Q4 2025 | 127 | $1.7B | TBBK, ESTA, HGV, SLNO, XTNT |
| Q3 2025 | 127 | $1.6B | ESTA, HGV, TBBK, QURE, SLNO |
| Q2 2025 | 133 | $1.4B | SLNO, HGV, ESTA, TBBK, XTNT |
| Q1 2025 | 126 | $1.2B | SLNO, HGV, ESTA, EOLS, TBBK |
| Q4 2024 | 118 | $1.4B | SLNO, ESTA, HGV, PTON, TBBK |
| Q3 2024 | 119 | $1.2B | SLNO, ESTA, BVS, PTON, EOLS |
| Q2 2024Amended | 113 | $994.2M | SLNO, ESTA, PTON, EOLS, BVS |
| Q1 2024 | 107 | $1.0B | SLNO, ESTA, CASH, EOLS, IMAX |